Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04070157 · ClinicalTrials.gov registry record · Phase 2
Randomized, Double-Blind, Placebo-Controlled Pilot Study on the Safety and Effectiveness of LUCEMYRA During an Opioid Taper in Treatment of Withdrawal
A Phase 2 study, sponsored by USWM, LLC (dba US WorldMeds).
- Terminated
- Registry status
- Phase 2
- Development phase
- 4
- Enrollment target
NCT04070157 is a Phase 2 study that was terminated before completion, run by USWM, LLC (dba US WorldMeds). The registered enrollment target is 4 participants.
The verdict
NCT04070157, a Phase 2 study, was terminated before completion, sponsored by USWM, LLC (dba US WorldMeds).
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 4 participants
- Enrollment target
Study Summary
Stopping prescription opioid pain medications can be difficult due to withdrawal symptoms. This study will test if LUCEMYRA helps reduce withdrawal symptoms and helps more people reduce their opioid dose compared to placebo.
Interventions
- DRUG Placebo
- DRUG Lofexidine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2019-08-02 |
| Est. Completion | 2019-11-27 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04070157
The ClinicalTrials.gov registry entry for NCT04070157 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is USWM, LLC (dba US WorldMeds), which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04070157 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04070157 about?
NCT04070157 is a clinical study titled "Randomized, Double-Blind, Placebo-Controlled Pilot Study on the Safety and Effectiveness of LUCEMYRA During an Opioid Taper in Treatment of Withdrawal". Stopping prescription opioid pain medications can be difficult due to withdrawal symptoms. This study will test if LUCEMYRA helps reduce withdrawal symptoms and helps more people reduce their opioid dose compared to placebo.
What is the current status of trial NCT04070157?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 4 participants. The study started on 2019-08-02. Estimated completion is 2019-11-27.
What interventions are being tested in trial NCT04070157?
The interventions under investigation include: Placebo (DRUG), Lofexidine (DRUG).
Who is sponsoring clinical trial NCT04070157?
This trial is sponsored by USWM, LLC (dba US WorldMeds), which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.